VITALITY
Report
- Report Number
- 2124215-2015-07512
- Event Type
- Malfunction
- Date Received
- July 1, 2015
- Date of Event
- May 5, 2014
- Report Date
- May 28, 2015
- Manufacturer
- GUIDANT CRM CLONMEL IRELAND
- Product Code
- LWS
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- OTHER
Narratives
(B)(4). UPON RECEIPT IN OUR POST MARKET QUALITY ASSURANCE LABORATORY, VISUAL INSPECTION NOTED THAT THE DEVICE HEADER WAS LOOSE BUT NOT SEPARATED FROM THE DEVICE. X-RAY EXAMINATION CONFIRMED THAT THE DEVICE RV TIP, A TIP, A RING, DF+ AND DF- FEED-THRU WIRES WERE FRACTURED. AN ENGINEERING-LEVEL LONGEVITY PREDICTION CALCULATION WAS COMPLETED TO ASSESS THE RATE OF BATTERY DEPLETION. GIVEN THE PROGRAMMED PARAMETERS AND OTHER DATA STORED WITHIN THE MEMORY OF THE DEVICE, THE RESULTS OF THIS CALCULATION INDICATED THAT THE ACTUAL RATE OF BATTERY DEPLETION FELL WITHIN AN ACCEPTABLE RANGE. THERAPY TESTING ON THE DEVICE WAS UNABLE TO BE PERFORMED AS A RESULT OF THE FRACTURED FEED-THRU WIRES, HOWEVER EXAMINATION OF THE DEVICE MEMORY SHOWED THAT ALL DEVICE LEAD IMPEDANCE MEASUREMENTS WERE GOOD AT THE TIME OF EXPLANT AND THAT THERAPY WAS AVAILABLE AT TIME OF EXPLANT. EVIDENCE INDICATES THAT THE LOOSE HEADER WAS CAUSED BY EXTERNAL STRESS DURING THE EXPLANT PROCEDURE. MANUFACTURING ENHANCEMENTS HAVE BEEN IMPLEMENTED TO MAKE THE HEADER BOND MORE ROBUST.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT RECEIVED AN INAPPROPRIATE SHOCK FOR ATRIAL FIBRILLATION WITH RIGHT VENTRICULAR RESPONSE. BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) WAS CONSULTED AND DISCUSSED PROGRAMMING OPTIONS. THE FOLLOWING DAY THE PATIENT PRESENTED TO THE EMERGENCY ROOM WITH COMPLAINTS OF HEARING TONES FROM THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD). IT WAS NOTED THAT THERE WERE NO ISSUES WITH THE DEVICE FOUND UPON INTERROGATION AND THE PATIENT HAD NOT RECEIVED A SHOCK ON THAT DAY. THE PHYSICIAN OPTED TO CONTINUE TO MONITOR THE PATIENT. TWO MONTHS LATER THE PHYSICIAN PERFORMED NON-INVASIVE PROGRAMMED STIMULATION (NIPS) TESTING IN ORDER TO DETERMINE THE CORRECT PROGRAMMING FOR THE PATIENT. THE SYSTEM REMAINED IMPLANTED WITH NO FURTHER ISSUES. THE ICD WAS EXPLANTED EIGHT MONTHS LATER FOR ELECTIVE REPLACEMENT INDICATOR (ERI). NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 428689 | VITALITY | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR | LWS | GUIDANT CRM CLONMEL IRELAND | T180 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 65 YR | T180| 0158| 4087 |